Benzodiazepines in epilepsy: pharmacology and pharmacokinetics

@article{Riss2008BenzodiazepinesIE,
  title={Benzodiazepines in epilepsy: pharmacology and pharmacokinetics},
  author={Jennifer Riss and James C. Cloyd and John R. Gates and Stephen D. Collins},
  journal={Acta Neurologica Scandinavica},
  year={2008},
  volume={118}
}
Benzodiazepines (BZDs) remain important agents in the management of epilepsy. They are drugs of first choice for status epilepticus and seizures associated with post‐anoxic insult and are also frequently used in the treatment of febrile, acute repetitive and alcohol withdrawal seizures. Clinical advantages of these drugs include rapid onset of action, high efficacy rates and minimal toxicity. Benzodiazepines are used in a variety of clinical situations because they have a broad spectrum of… Expand
Clinically Significant Interactions with Benzodiazepines
TLDR
This chapter will review the varied kinetics of available benzodiazepines and discuss the metabolic pathways leading to excretion of these medications and identify the clinical monitoring that is required for individuals being prescribed benzdiazepines including respiratory depression, sedation, and withdrawal. Expand
Reduced efficacy and risk of seizure aggravation when cannabidiol is used without clobazam
TLDR
Clobazam is widely used in the chronic treatment of focal and generalized seizures, and has application in the treat18 ment of diverse epilepsy syndromes, and there is evidence that partial agonists at the benzodiazepine site of GABAA receptors exhibit less propensity for the development of anticonvulsant tolerance than full agonists. Expand
Single dose efficacy evaluation of two partial benzodiazepine receptor agonists in photosensitive epilepsy patients: A placebo-controlled pilot study
TLDR
The study substantiates previous pre-clinical experiments that abecarnil exerts pronounced anti-seizure activity and suggests that the anxiolytic activity of abec Carnil would be an added advantage when using this compound in epilepsy patients. Expand
Antiepileptic drugs
Purpose of Review: Treatment of epilepsy starts with antiepileptic drug (AED) monotherapy. Knowledge of the spectrum of efficacy, clinical pharmacology, and modes of use for individual AEDs isExpand
Benzodiazepines for prolonged seizures
  • Mark Anderson
  • Medicine
  • Archives of Disease in Childhood: Education & Practice Edition
  • 2010
TLDR
Diazepam, lorazepam and midazolam, the drugs most widely used to stop prolonged seizures, are members of the benzodiazepine family, a class of psychoactive drugs with varying hypnotic, sedative, anxiolytic, anticonvulsant, muscle relaxant and amnesic properties. Expand
Steering the pharmacological treatment along different metabolic pathways in response to outlying complicated benzodiazepine withdrawal – a case study
TLDR
Lorazepam, short-acting but bypassing the accelerated metabolic pathway, at sufficient doses provided the satiation necessary to stabilize the patient, and the breakthrough occurred when lorZepam was used instead of previously administered substitute BZDs. Expand
Clonazepam: Indications, Side Effects, and Potential for Nonmedical Use.
TLDR
There is a need to find safer therapeutic alternatives for treating seizures and anxiety disorders and greater awareness of its frequent nonmedical use is also needed to achieve safer overall use of this medication. Expand
Levetiracetam: a review of its use in epilepsy.
TLDR
Oral levetiracetam provided seizure control relative to placebo as adjunctive therapy in patients with idiopathic generalized epilepsy with myoclonic seizures or GTC seizures and showed improvements in measures of health-related quality of life relative to those receiving placebo. Expand
New approach for detoxification of patients dependent on benzodiazepines and Z-drugs for reduction of psychogenic complications.
TLDR
Individually prepared pharmaceutics with different and precise diazepam contents can be used for comfortable detoxification and also may eliminate psychogenic stress during switching, tapering, and the withdrawal period. Expand
Imidazenil, a non-sedating anticonvulsant benzodiazepine, is more potent than diazepam in protecting against DFP-induced seizures and neuronal damage.
TLDR
The combination of atropine and imidazenil is at least 10-fold more potent and longer lasting than the combination with diazepam at protecting rats from DFP-induced seizures and the associated neuronal damage or ongoing degeneration in the anterior cingulate cortex, CA1 hippocampus, and dentate gyrus. Expand
...
1
2
3
4
5
...

References

SHOWING 1-10 OF 243 REFERENCES
Guidelines for the clinical use of benzodiazepines: pharmacokinetics, dependency, rebound and withdrawal. Canadian Society for Clinical Pharmacology.
  • J. Nelson, G. Chouinard
  • Medicine
  • The Canadian journal of clinical pharmacology = Journal canadien de pharmacologie clinique
  • 1999
Principles of benzodiazepine selection are outlined for various psychiatric indications and diverse populations (the elderly, and drug and alcohol abusers). Benzodiazepines are still among the mostExpand
Pharmacokinetic Optimisation of Benzodiazepine Therapy for Acute Seizures
TLDR
Although diazepam was initially chosen for the management of refractory status epilepticus, the longer duration of action of lorazepam and clonazep am may favour the use of these 2 drugs, and double-blind evaluations are necessary to determine which drug is best. Expand
Benzodiazepines in the treatment of epilepsy in people with intellectual disability.
TLDR
Despite the limitations of BZDs in the prophylactic treatment of epilepsies, these drugs play a prominent role in clinical practice in the emergency management of acute seizures and status epilepticus. Expand
Issues in the clinical use of benzodiazepines: potency, withdrawal, and rebound.
  • G. Chouinard
  • Psychology, Medicine
  • The Journal of clinical psychiatry
  • 2004
TLDR
Although as a class benzodiazepines act rapidly and are well tolerated, their use presents clinical issues such as dependence, rebound anxiety, memory impairment, and discontinuation syndrome. Expand
Pharmacokinetic optimization of benzodiazepine therapy for acute seizures. Focus on delivery routes.
TLDR
Although diazepam was initially chosen for the management of refractory status epilepticus, the longer duration of action of lorazepam and clonazep am may favour the use of these 2 drugs, and double-blind evaluations are necessary to determine which drug is best. Expand
Guidelines for the rational use of benzodiazepines. When and what to use.
TLDR
Indications for benzodiazepines include acute stress reactions, episodic anxiety, fluctuations in generalised anxiety, and as initial treatment for severe panic and agoraphobia, and occasionally in acute psychoses. Expand
Pharmacokinetics of benzodiazepines. Short-acting versus long-acting.
TLDR
A review is given of the pharmacokinetics of the major benzodiazepines presently available and suggests that compounds with long elimination half-lives of parent drug or active metabolites are of advantage in anticonvulsant and anti-anxiety treatment. Expand
Benzodiazepines: some aspects of their clinical pharmacology.
TLDR
There are differences among benzodiazepines in patterns of absorption, distribution, and elimination by the human body, which may lead to apparent differences in clinical action. Expand
The Use of Clobazam, Midazolam, and Nitrazepam in Epilepsy
Summary: The benzodiazepines clobazam (CLB), midazolam (MDL), and nitrazepam (NZP) all have proven efficacy in epilepsy management, but their differences in physical properties, pharmacokineticExpand
The Importance of Drug Interactions in Epilepsy Therapy
TLDR
Physicians prescribing AEDs to patients with epilepsy must, therefore, be aware of the potential for drug interactions and the effects (pharmacokinetic and pharmacodynamic) that can occur both during combination therapy and on drug discontinuation. Expand
...
1
2
3
4
5
...